These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8840357)

  • 1. Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls.
    Michelson D; Altemus M; Galliven E; Hill L; Greenberg BD; Gold P
    Neuropsychopharmacology; 1996 Aug; 15(2):207-12. PubMed ID: 8840357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
    Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone.
    Adinoff B; Krebaum SR; Chandler PA; Ye W; Brown MB; Williams MJ
    Alcohol Clin Exp Res; 2005 Apr; 29(4):528-37. PubMed ID: 15834217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
    Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression.
    Burnett FE; Scott LV; Weaver MG; Medbak SH; Dinan TG
    J Affect Disord; 1999 Jun; 53(3):263-8. PubMed ID: 10404712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man.
    Delitala G; Trainer PJ; Oliva O; Fanciulli G; Grossman AB
    J Endocrinol; 1994 Apr; 141(1):163-8. PubMed ID: 8031419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation that offspring from families with alcohol-dependent individuals have greater hypothalamic-pituitary-adrenal axis activation induced by naloxone compared with offspring without a family history of alcohol dependence.
    Wand G; McCaul ME; Gotjen D; Reynolds J; Lee S
    Alcohol Clin Exp Res; 2001 Aug; 25(8):1134-9. PubMed ID: 11505044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous opioid tone in patients with rheumatoid arthritis.
    Kassimos D; Choy EH; Grossman AB; Chikanza IC; Panayi GS
    Br J Rheumatol; 1996 May; 35(5):436-40. PubMed ID: 8646433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucocorticoid antagonism with RU 486 on pituitary-adrenal function in patients with major depression: time-dependent enhancement of plasma ACTH secretion.
    Kling MA; Whitfield HJ; Brandt HA; Demitrack MA; Kalogeras K; Geracioti TD; Perini GI; Calabrese JR; Chrousos GP; Gold PW
    Psychopharmacol Bull; 1989; 25(3):466-72. PubMed ID: 2560555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary-adrenal responses to combined oral D-fenfluramine and intravenous naloxone in humans.
    Grice JE; Torpy DJ; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):621-3. PubMed ID: 9673439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
    Alexander SL; Irvine CH; Donald RA
    Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in the ACTH response to 24H metyrapone in depression.
    Young EA; Ribeiro SC
    Brain Res; 2006 Dec; 1126(1):148-55. PubMed ID: 16824495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men.
    Wand GS; Mangold D; Ali M
    J Clin Endocrinol Metab; 1999 Jan; 84(1):64-8. PubMed ID: 9920063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.